D-Sight S.L.

D-Sight S.L. is a biotechnology startup based in Spain, founded in 2023. It is a spin-off company from Vall d’Hebron Institute of Research (VHIR) with a focus on developing new innovative treatments for neurodegenerative diseases of the retina. The company's dedicated team is committed to shaping the future of retinal disease treatment. Their first product in development is a first-in-class eye drop formulation for the prevention and treatment of diabetic retinopathy in its early stages. D-Sight S.L. recently secured a €1.00M Seed Round - D investment on 03 May 2023, with the funding coming from Clave Capital. This investment signifies confidence in the company's vision and potential impact in the biotechnology and health care industries. With a strong founding team and a promising first product in the pipeline, D-Sight S.L. has the potential to make significant strides in addressing retinal diseases, offering hope for improved treatment options in the near future.